LUSPATERCEPT - A better strategy for thalassemia?

J Pak Med Assoc. 2021 Aug;71(8):2107. doi: 10.47391/JPMA.773.
No abstract available

MeSH terms

  • Activin Receptors, Type II
  • Humans
  • Immunoglobulin Fc Fragments
  • Recombinant Fusion Proteins
  • Thalassemia* / drug therapy
  • beta-Thalassemia*

Substances

  • Immunoglobulin Fc Fragments
  • Recombinant Fusion Proteins
  • luspatercept
  • Activin Receptors, Type II